2020 EAPCI core curriculum for percutaneous cardiovascular interventions

Eric Van Belle; Rui C. Teles; Stylianos A. Pyxaras; Oliver Kalpak; Thomas Johnson; Israel Moshe Barbash; Giuseppe De Luca; Jorgo Kostov; Radoslaw Parma; Flavien Vincent; Salvatore Brugaletta; Nicolas Debry; Gabor G. Toth; Ziyad Ghazzal; Pierre Deharo; Dejan Milasinovic; Klaus Kaspar; Francesco Saia; Josepa Mauri; Jürgen Kammler; Douglas Muir; Stephen O'Connor; Julinda Mehilli; Holger Thiele; Daniel Weilenmann; Nils Witt; Francis Joshi; Rajesh Kharbanda; Zsolt Piroth; Wojciech Wojakowski; Alexander Geppert; Giuseppe Di Gioia; Gustavo Pires-Morais; Anna Sonia Petronio; Rodrigo Estévez-Loureiro; Zoltan Ruzsa; Joelle Kefer; Vijay Kunadian; Nicolas Van Mieghem; Stephan Windecker; Andreas Baumbach; Michael Haude; Dariusz Dudek

doi:10.4244/EIJ-D-18-00448

2020 EAPCI core curriculum for percutaneous cardiovascular interventions

Eric Van Belle, Rui C. Teles, Stylianos A. Pyxaras, Oliver Kalpak, Thomas Johnson, Israel Moshe Barbash, Giuseppe De Luca, Jorgo Kostov, Radoslaw Parma, Flavien Vincent, Salvatore Brugaletta, Nicolas Debry, Gabor G. Toth, Ziyad Ghazzal, Pierre Deharo, Dejan Milasinovic, Klaus Kaspar, Francesco Saia, Josepa Mauri, Jürgen KammlerDouglas Muir, Stephen O'Connor, Julinda Mehilli, Holger Thiele, Daniel Weilenmann, Nils Witt, Francis Joshi, Rajesh Kharbanda, Zsolt Piroth, Wojciech Wojakowski, Alexander Geppert, Giuseppe Di Gioia, Gustavo Pires-Morais, Anna Sonia Petronio, Rodrigo Estévez-Loureiro, Zoltan Ruzsa, Joelle Kefer, Vijay Kunadian, Nicolas Van Mieghem, Stephan Windecker, Andreas Baumbach, Michael Haude, Dariusz Dudek

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

23 Downloads (Pure)

Abstract

The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an updated European consensus that defines the level of experience and knowledge in the field of percutaneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of competencies at the European level and the free movement of certified specialists in the European Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from previous EAPCI core curricula and from the "2013 core curriculum of the general cardiologist"to follow the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unanimous - consensus among the task force members on the training required for the interventional cardiologist of the future. The document recommends that acquisition of competence in interventional cardiology requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes.

Original language	English
Pages (from-to)	23-31
Number of pages	9
Journal	EuroIntervention
Volume	17
Issue number	1
DOIs	https://doi.org/10.4244/EIJ-D-18-00448
Publication status	Published - May 2021

Keywords

Miscellaneous

Access to Document

10.4244/EIJ-D-18-00448

eapci-core-curriculum-for-percutaneous-cardiovascular-interventions-2020committeFinal published version, 494 KBLicence: CC BY

Cite this

Van Belle, E., Teles, R. C., Pyxaras, S. A., Kalpak, O., Johnson, T., Barbash, I. M., De Luca, G., Kostov, J., Parma, R., Vincent, F., Brugaletta, S., Debry, N., Toth, G. G., Ghazzal, Z., Deharo, P., Milasinovic, D., Kaspar, K., Saia, F., Mauri, J., ... Dudek, D. (2021). 2020 EAPCI core curriculum for percutaneous cardiovascular interventions. EuroIntervention, 17(1), 23-31. https://doi.org/10.4244/EIJ-D-18-00448

@article{b0691549e75c40e9a8f3ab8308e20d8b,

title = "2020 EAPCI core curriculum for percutaneous cardiovascular interventions",

abstract = "The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an updated European consensus that defines the level of experience and knowledge in the field of percutaneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of competencies at the European level and the free movement of certified specialists in the European Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from previous EAPCI core curricula and from the {"}2013 core curriculum of the general cardiologist{"}to follow the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unanimous - consensus among the task force members on the training required for the interventional cardiologist of the future. The document recommends that acquisition of competence in interventional cardiology requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes. ",

keywords = "Miscellaneous",

author = "{Van Belle}, Eric and Teles, {Rui C.} and Pyxaras, {Stylianos A.} and Oliver Kalpak and Thomas Johnson and Barbash, {Israel Moshe} and {De Luca}, Giuseppe and Jorgo Kostov and Radoslaw Parma and Flavien Vincent and Salvatore Brugaletta and Nicolas Debry and Toth, {Gabor G.} and Ziyad Ghazzal and Pierre Deharo and Dejan Milasinovic and Klaus Kaspar and Francesco Saia and Josepa Mauri and J{\"u}rgen Kammler and Douglas Muir and Stephen O'Connor and Julinda Mehilli and Holger Thiele and Daniel Weilenmann and Nils Witt and Francis Joshi and Rajesh Kharbanda and Zsolt Piroth and Wojciech Wojakowski and Alexander Geppert and {Di Gioia}, Giuseppe and Gustavo Pires-Morais and Petronio, {Anna Sonia} and Rodrigo Est{\'e}vez-Loureiro and Zoltan Ruzsa and Joelle Kefer and Vijay Kunadian and {Van Mieghem}, Nicolas and Stephan Windecker and Andreas Baumbach and Michael Haude and Dariusz Dudek",

note = "Funding Information: A. Baumbach received institutional research support from Abbott Vascular, consultation and speaker fees from AstraZeneca, Sinomed, MicroPort, Abbott Vascular, Cardinal Health, KSH, and Medtronic. R. Estevez-Loureiro reports grants and personal fees from Abbott Vascular and personal fees from Boston Scientific, outside the submitted work. A. Geppert reports lecture fees from Medtronic, Abbott and Abiomed, consulting fees from Abbott and Abiomed, congress grants from Asahi and Terumo, outside the submitted work. J. Kefer reports proctorship and speaker fees from Medtronic and Abbott, and speaker fees from Servier. D. Milasinovic reports personal fees from Abbot, Biosensors, Terumo, AstraZeneca and Sanofi, outside the submitted work. D. Muir is a proctor and advisory board member for Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. A.S. Petronio received proctor and advisory board fees from Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. G. Pires-Morais received speaker fees from Abbott Vascular. S. Pyxaras received consultancy fees from Abiomed and Boston Scientific and proctor fees from Boston Scientific. R. Parma received speaker fees from Boston Scientific, Edwards Lifesciences and Medtronic. F. Saia reports personal fees from Abbott Vascular, Boston Scientific, Edwards, Medtronic, Biotronik, Amgen, AstraZeneca, Daiichi Sankyo, Bayer and Boehringer-Ingelheim, outside the submitted work. N. Van Mieghem reports advisor fees from PulseCath BV and Abiomed. S. Windecker reports grants from Abbott, Amgen, BMS, Bayer, Boston Scientific, Biotronik, Cardinal Health, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Johnson and Johnson, Medtronic, Quebert, Polares, Sanofi and Terumo, outside the submitted work. E. Van Belle reports personal fees from HeartFlow and Philips, outside the submitted work. The other authors have no conflicts of interest to declare. Publisher Copyright: {\textcopyright} Europa Digital & Publishing 2021. All rights reserved.",

year = "2021",

month = may,

doi = "10.4244/EIJ-D-18-00448",

language = "English",

volume = "17",

pages = "23--31",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "1",

}

Van Belle, E, Teles, RC, Pyxaras, SA, Kalpak, O, Johnson, T, Barbash, IM, De Luca, G, Kostov, J, Parma, R, Vincent, F, Brugaletta, S, Debry, N, Toth, GG, Ghazzal, Z, Deharo, P, Milasinovic, D, Kaspar, K, Saia, F, Mauri, J, Kammler, J, Muir, D, O'Connor, S, Mehilli, J, Thiele, H, Weilenmann, D, Witt, N, Joshi, F, Kharbanda, R, Piroth, Z, Wojakowski, W, Geppert, A, Di Gioia, G, Pires-Morais, G, Petronio, AS, Estévez-Loureiro, R, Ruzsa, Z, Kefer, J, Kunadian, V, Van Mieghem, N, Windecker, S, Baumbach, A, Haude, M & Dudek, D 2021, '2020 EAPCI core curriculum for percutaneous cardiovascular interventions', EuroIntervention, vol. 17, no. 1, pp. 23-31. https://doi.org/10.4244/EIJ-D-18-00448

TY - JOUR

T1 - 2020 EAPCI core curriculum for percutaneous cardiovascular interventions

AU - Van Belle, Eric

AU - Teles, Rui C.

AU - Pyxaras, Stylianos A.

AU - Kalpak, Oliver

AU - Johnson, Thomas

AU - Barbash, Israel Moshe

AU - De Luca, Giuseppe

AU - Kostov, Jorgo

AU - Parma, Radoslaw

AU - Vincent, Flavien

AU - Brugaletta, Salvatore

AU - Debry, Nicolas

AU - Toth, Gabor G.

AU - Ghazzal, Ziyad

AU - Deharo, Pierre

AU - Milasinovic, Dejan

AU - Kaspar, Klaus

AU - Saia, Francesco

AU - Mauri, Josepa

AU - Kammler, Jürgen

AU - Muir, Douglas

AU - O'Connor, Stephen

AU - Mehilli, Julinda

AU - Thiele, Holger

AU - Weilenmann, Daniel

AU - Witt, Nils

AU - Joshi, Francis

AU - Kharbanda, Rajesh

AU - Piroth, Zsolt

AU - Wojakowski, Wojciech

AU - Geppert, Alexander

AU - Di Gioia, Giuseppe

AU - Pires-Morais, Gustavo

AU - Petronio, Anna Sonia

AU - Estévez-Loureiro, Rodrigo

AU - Ruzsa, Zoltan

AU - Kefer, Joelle

AU - Kunadian, Vijay

AU - Van Mieghem, Nicolas

AU - Windecker, Stephan

AU - Baumbach, Andreas

AU - Haude, Michael

AU - Dudek, Dariusz

N1 - Funding Information: A. Baumbach received institutional research support from Abbott Vascular, consultation and speaker fees from AstraZeneca, Sinomed, MicroPort, Abbott Vascular, Cardinal Health, KSH, and Medtronic. R. Estevez-Loureiro reports grants and personal fees from Abbott Vascular and personal fees from Boston Scientific, outside the submitted work. A. Geppert reports lecture fees from Medtronic, Abbott and Abiomed, consulting fees from Abbott and Abiomed, congress grants from Asahi and Terumo, outside the submitted work. J. Kefer reports proctorship and speaker fees from Medtronic and Abbott, and speaker fees from Servier. D. Milasinovic reports personal fees from Abbot, Biosensors, Terumo, AstraZeneca and Sanofi, outside the submitted work. D. Muir is a proctor and advisory board member for Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. A.S. Petronio received proctor and advisory board fees from Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. G. Pires-Morais received speaker fees from Abbott Vascular. S. Pyxaras received consultancy fees from Abiomed and Boston Scientific and proctor fees from Boston Scientific. R. Parma received speaker fees from Boston Scientific, Edwards Lifesciences and Medtronic. F. Saia reports personal fees from Abbott Vascular, Boston Scientific, Edwards, Medtronic, Biotronik, Amgen, AstraZeneca, Daiichi Sankyo, Bayer and Boehringer-Ingelheim, outside the submitted work. N. Van Mieghem reports advisor fees from PulseCath BV and Abiomed. S. Windecker reports grants from Abbott, Amgen, BMS, Bayer, Boston Scientific, Biotronik, Cardinal Health, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Johnson and Johnson, Medtronic, Quebert, Polares, Sanofi and Terumo, outside the submitted work. E. Van Belle reports personal fees from HeartFlow and Philips, outside the submitted work. The other authors have no conflicts of interest to declare. Publisher Copyright: © Europa Digital & Publishing 2021. All rights reserved.

PY - 2021/5

Y1 - 2021/5

N2 - The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an updated European consensus that defines the level of experience and knowledge in the field of percutaneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of competencies at the European level and the free movement of certified specialists in the European Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from previous EAPCI core curricula and from the "2013 core curriculum of the general cardiologist"to follow the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unanimous - consensus among the task force members on the training required for the interventional cardiologist of the future. The document recommends that acquisition of competence in interventional cardiology requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes.

AB - The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an updated European consensus that defines the level of experience and knowledge in the field of percutaneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of competencies at the European level and the free movement of certified specialists in the European Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from previous EAPCI core curricula and from the "2013 core curriculum of the general cardiologist"to follow the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unanimous - consensus among the task force members on the training required for the interventional cardiologist of the future. The document recommends that acquisition of competence in interventional cardiology requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes.

KW - Miscellaneous

UR - http://www.scopus.com/inward/record.url?scp=85106552066&partnerID=8YFLogxK

U2 - 10.4244/EIJ-D-18-00448

DO - 10.4244/EIJ-D-18-00448

M3 - Article

C2 - 32624457

AN - SCOPUS:85106552066

VL - 17

SP - 23

EP - 31

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 1

ER -

2020 EAPCI core curriculum for percutaneous cardiovascular interventions

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this